Director of Comparative Biology and Medicine, GlaxoSmithKline, Adjunct Professor of Pathology, Duke University School of MedicineBiography
Jeff Everitt received his DVM from Cornell University and then completed a residency in comparative pathology at the University of Pennsylvania and a postdoctoral research appointment at the University of Illinois. Dr. Everitt served for 17 years on the senior scientific staff of the CIIT Centers for Health Research where he attained Senior Scientist status. At CIIT he led the animal care and use program as well as a multidisciplinary research program that examined the health effects of inhaled fibrous particulate. He currently serves as a Director of Comparative Biology and Medicine at GlaxoSmithKline and as an Adjunct Professor of Pathology at Duke University School of Medicine in Durham, NC. Dr. Everitt is board certified in anatomic pathology (ACVP) and in laboratory animal medicine (ACLAM) and is a Fellow in the International Academy of Toxicologic Pathologists (FIATP). He has served in leadership positions in multiple professional organizations in laboratory animal science, pathology and toxicology during the past twenty years. Dr. Everitt has lectured and published widely on best practices for the control of variability and bias in the conduct of in vivo studies.